TABLE 6. Effects of noradrenergic agonists on ethanol-induced sleep and noradrenergic antagonists on TRH reduction of ahanol-induced sleep in mice.
Treatment | Dose | Sleeping Time | Rectal Temperature |
---|---|---|---|
min ± S.E.M. | °C ± S.E.M. | ||
A. Noradrenergic agonists | |||
Saline | 91.0 ± 4.8 | 35.6 ± 0.14 | |
l-Norepinephrine | 0.2 μg | 103.6 ± 7.1 | 35.6 ± 0.26 |
5 μg | 113.9 ± 14.3 | 37.3 ± 0.17d | |
30 μg | 150.0 ± 15.0c | 35.5 ± 0.27 | |
Xylometazoline | 0.2 μg | 138.9 ± 17.9 | 34.5 ± 0.29a |
5 μg | 109.4 ± 17.3 | 35.0 ± 0.19 | |
20 μg | 132.6 ± 13.5 | 34.8 ± 0.17b | |
d-Amphetamine | 4 μg | 91.4 ± 9.5 | 35.1 ± 0.33 |
8 μg | 80.6 ± 10.8 | 36.8 ± 0.45 | |
50 μg | 76.6 ± 7.9 | 37.3 ± 0.32d | |
100 μg | 93.2 ± 8.9 | 38.2 ± 0.24d | |
B. Noradrenergic antagonists and TRH | |||
Saline | 82.8 ± 4.4 | 35.6 ± 0.10 | |
TRH | 10 mg/kg | 51.8 ± 35c | 37.1 ± 0.17d |
α-Methyltyrosine | 300 mg/kg | 83.0 ± 9.5 | 35.5 ± 0.21 |
α-Methyltyrosine + TRH | 300 mg/kg + 10 mg/kg | 40.9 ± 55e | 37.0 ± 0.21g |
dl-Propranolol | 5 μg | 98.5 + 12.3 | |
10 μg | 63.3 ± 5.3d | 35.1 ± 0.21 | |
20 μg | 77.8 ± 5.1 | 34.6 ± 0.20d | |
35 μg | 83.3 ± 7.2 | 35.1 ± 0.19 | |
dl-Propranolol + TRH | 10 μg + 10 mg/kg | 40.6 ± 3.8g | 36.4 ± 0.19g |
20 μg + 10 mg/kg | 55.6 ± 5.8f | 35.7 ± 0.28g | |
35 μg + 10 mg/kg | 60.3 ± 5.6e | 35.8 ± 0.12g | |
Phentolamine | 2 μg | 147.4 ± 19.3d | 35.5 ± 0.11 |
Phentolamine + TRH | 2 μg + 10 mg/kg | 61.7 ± 77g | 36.0 ± 0.12f |
When compared with saline:
P < .05.
P < .025.
P < .005.
P < .001.
When compared with treated group without TRH:
P < .02.
P < .01.
p < .005.